Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Membrane-associated ring-CH-type finger protein 10 (MARCHF10) is a member of the MARCH family of membrane-bound E3 ubiquitin ligases. These enzymes catalyze the transfer of ubiquitin to lysine residues of substrate proteins, often targeting them for proteasomal degradation or affecting their membrane localization and stability. MARCHF10 is predicted to contain a RING-CH domain (a variant of the canonical RING finger domain) and likely binds zinc ions as part of its structural motif. MARCH family proteins, including MARCHF10, act as critical regulators of immune responses by targeting immune receptors, viral proteins, and other membrane proteins for ubiquitination, thereby modulating their expression or activity at the cell surface. This regulation is relevant to processes such as immune surveillance, inflammation, and cellular homeostasis. Dysregulation of MARCH family ligases has been implicated in cancer, metabolic diseases, immune disorders, and primary ciliary dyskinesia. Although the biological context of MARCHF10's direct therapeutic targeting remains under investigation, E3 ubiquitin ligases are emerging as important drug targets because of their key regulatory roles in health and disease. No specific therapeutic drugs or biomarkers have yet been established for MARCHF10, but safety concerns for this family include risks of immune perturbation and off-target protein degradation due to broad substrate specificity.
Ubiquitination of substrate proteins, Targeted proteasomal degradation, Posttranslational modification of membrane or signaling proteins
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Membrane-associated ring-CH-type finger protein 10 (MARCHF10).